日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Escape from cell uptake: Drug-Free cancer therapeutics regulated by hydrophobicity and negative charge

逃避细胞摄取:受疏水性和负电荷调控的无药物癌症疗法

Moroishi, Kazuki; Nakamoto, Masahiko; Fujita, Satoshi; Kawahara, Marie; Katayama, Ryohei; Matsusaki, Michiya

Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity

阿法替尼对T细胞介导的细胞毒性具有抑制作用。

Yokomura, Masaru; Nagano, Seiji; Kawamoto, Hiroshi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Asakage, Takahiro; Katayama, Ryohei

Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma.

MCL1 拷贝数频繁增加是骨肉瘤的治疗靶点

Takagi Satoshi, Nakajima Mikako, Koike Sumie, Takami Miho, Sugiura Yoshiya, Sakata Seiji, Baba Satoko, Takemoto Ai, Huang Tianyi, Seto Yosuke, Saito Masanori, Funauchi Yuki, Ae Keisuke, Takeuchi Kengo, Fujita Naoya, Katayama Ryohei

Inhibition of anti-apoptotic Bcl-2 family members promotes synergistic cell death with ER stress inducers by disrupting autophagy in glioblastoma

抑制抗凋亡的Bcl-2家族成员可通过破坏胶质母细胞瘤中的自噬,促进与内质网应激诱导剂的协同细胞死亡。

Huang, Tianyi; Takagi, Satoshi; Koike, Sumie; Katayama, Ryohei

Combined blockade of GPX4 and activated EGFR/HER3 bypass pathways inhibits the development of ALK-inhibitor-induced tolerant persister cells in ALK-fusion-positive lung cancer

GPX4 和激活的 EGFR/HER3 旁路通路联合阻断可抑制 ALK 融合阳性肺癌中 ALK 抑制剂诱导的耐受性持续细胞的形成。

Furugaki, Koh; Fujimura, Takaaki; Sakaguchi, Narumi; Watanabe, Yasutaka; Uchibori, Ken; Miyauchi, Eisaku; Hayashi, Hidetoshi; Katayama, Ryohei; Yoshiura, Shigeki

Novel Approach to Overcome Osimertinib Resistance Using Bromodomain and Extra-Terminal Domain Inhibitors

利用溴结构域和末端结构域抑制剂克服奥希替尼耐药性的新方法

Miyashita, Yosuke; Tajima, Ken; Izumi, Kenta; Matsumoto, Naohisa; Hayakawa, Daisuke; Nakamura, Ikuko Takeda; Katayama, Isana; Wibowo, Adityo; Matsuda, Hironari; Winardi, Wira; Amien, Bagus Radityo; Mitsuishi, Yoichiro; Takahashi, Fumiyuki; Nakamura, Kohta; Uchibori, Ken; Yanagitani, Noriko; Hayashi, Takuo; Takamochi, Kazuya; Suzuki, Kenji; Katayama, Ryohei; Takahashi, Kazuhisa

Inhibition of ROS1 activity with lorlatinib reversibly suppresses fertility in male mice

使用洛拉替尼抑制ROS1活性可逆性地抑制雄性小鼠的生育能力。

Oyama, Yuki; Shimada, Kentaro; Miyata, Haruhiko; Iida-Norita, Rie; Emori, Chihiro; Kamoshita, Maki; Oura, Seiya; Katayama, Ryohei; Matzuk, Martin M; Ikawa, Masahito

Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer

靶向ErbB和tankyrase1/2可阻止ALK阳性肺癌中耐药性持续细胞的出现

Fujimura, Takaaki; Furugaki, Koh; Mizuta, Hayato; Muraoka, Satoshi; Nishio, Makoto; Adachi, Jun; Uchibori, Ken; Miyauchi, Eisaku; Hayashi, Hidetoshi; Katayama, Ryohei; Yoshiura, Shigeki

APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells

APC/PIK3CA突变和β-catenin状态可预测患者来源的结直肠癌细胞对tankyrase抑制剂的敏感性

Chen, Mingjue; Mashima, Tetsuo; Oishi, Taichi; Muramatsu, Yukiko; Seto, Yosuke; Takamatsu, Manabu; Kawata, Naomi; Morino, Shun; Nakamura, Ayane; Inaba, Saori; Yuan, Xunmei; Maruyama, Kohei; Suzuki, Mai; Sato, Ayana; Yoshida, Haruka; Jang, Myung-Kyu; Mizutani, Anna; Takeuchi, Kengo; Yamaguchi, Kensei; Shirai, Fumiyuki; Nagayama, Satoshi; Katayama, Ryohei; Seimiya, Hiroyuki

Identification of C-mannosylation in a receptor tyrosine kinase AXL

受体酪氨酸激酶 AXL 中 C-甘露糖基化的鉴定

Mori, Kento; Suzuki, Takehiro; Waki, Urara; Hayashi, Soichiro; Kadono, Shigehito; Kawahara, Ryota; Takeuchi, Minae; Mizuta, Hayato; Dohmae, Naoshi; Katayama, Ryohei; Simizu, Siro